BioCentury
ARTICLE | Financial News

SuperX raises $11M series A round

February 9, 2017 1:36 PM UTC

Anticoagulation play SuperX Ltd. (Cambridge, U.K.) raised $11 million in a series A round led by Medicxi. Johnson & Johnson Innovation-JJDC Inc. also participated.

The newco is developing preclinical antibodies against an undisclosed target to provide anticoagulation without increasing the risk of bleeding. The company expects to begin clinical studies of its lead program in 2019...